Who Owns Sana Biotechnology Stock?
NASDAQ: SANAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pre-market: 2.81 +0.72%
Ownership breakdown
- Held by institutions
- 77.71%
- Held by insiders
- 6.08%
- Institutional holders
- 275
- Institutions 77.7%
- Insiders 6.1%
- Public and other 16.2%
Who owns Sana Biotechnology stock?
Institutional investors own about 77.7% of Sana Biotechnology's shares, spread across 275 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.08% of SANA.
The largest institutional holders are FMR, LLC (12.50%), Flagship Pioneering LLC (8.35%) and RA Capital Management, L.P. (6.26%). Together, the top 10 institutions control 47.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their SANA positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SANA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 37.43M | 12.50% | 0.0% |
| Flagship Pioneering LLC | 25.00M | 8.35% | 0.0% |
| RA Capital Management, L.P. | 18.75M | 6.26% | +100.0% |
| Blackrock Inc. | 16.68M | 5.57% | +17.1% |
| State Street Corporation | 11.20M | 3.74% | +6.3% |
| Canada Pension Plan Investment Board | 10.22M | 3.41% | -0.0% |
| Vanguard Capital Management LLC | 8.38M | 2.80% | +12.7% |
| Bank of America Corporation | 5.75M | 1.92% | +95.1% |
| Geode Capital Management, LLC | 4.68M | 1.56% | +11.9% |
| Marex Group Ltd. | 3.99M | 1.33% | -0.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SANA
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 10.50M | 3.51% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 7.47M | 2.50% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6.25M | 2.09% |
| iShares Trust-iShares Russell 2000 ETF | 4.74M | 1.58% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 3.12M | 1.04% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 2.86M | 0.95% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.01M | 0.67% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.92M | 0.64% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.69M | 0.57% |
| iShares Trust-iShares Biotechnology ETF | 1.35M | 0.45% |
Frequently asked questions
Who is the largest shareholder of Sana Biotechnology?
FMR, LLC is the largest institutional shareholder of SANA, owning 12.50% of shares outstanding (37.43M shares) as of its latest 13F filing.
What percentage of Sana Biotechnology is owned by institutions?
Institutions own about 77.7% of SANA shares and 82.7% of the public float.
How much of Sana Biotechnology do insiders own?
Insiders, such as officers and directors, own about 6.08% of SANA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.